FDA to discuss what caused vaccine allergic reactions

COLUMBIA, Mo. (KMIZ)

The Food and Drug Administration is meeting Thursday to discuss red flags and oversights of the COVID-19 Pfizer vaccine.

The FDA has been working to understand what happened with the allergic reactions from the Pfizer vaccine, which was reported in the U.K. on Wednesday.

In a press release from the FDA, it believes the mistake was due to the fact that the clinical trials of the Pfizer vaccine did not include people with a history of allergic reactions.

As of now, the FDA reports there is not enough data to support the vaccine is safe and effective for people with a medical history of serious allergic reactions.

The FDA also plans to discuss if the Pfizer vaccine is effective in preventing COVID-19 in people 16 or older, and if potential benefits of the vaccine outweigh the risks.

The press release said the FDA is trying to see if any additional studies need to be conducted by the manufacturer on safety and effectiveness of the Pfizer vaccine.

According to the Associated Press, the panel of medical experts plan to vote on whether to endorse the vaccine, which will be followed by a final FDA decision and the first shots of the Pfizer vaccine.

The meeting will be held virtually from 9 a.m. to 6 p.m. eastern time.